University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma

Phase 2

Completed

Conditions: Stage IIIA Cutaneous Melanoma
Stage IIIC Cutaneous Melanoma
Stage IIIB Cutaneous Melanoma
Stage III Cutaneous Melanoma
Stage IV Cutaneous Melanoma

Interventions: Drug: Aspirin
Biological: Ipilimumab
Other: Laboratory Biomarker Analysis
Biological: Pembrolizumab

First Posted Date: 2018-01-11

Last Posted Date: 2022-10-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 27

Registration Number: NCT03396952

Locations: 🇺🇸
University of Califonia, San Francisco, San Francisco, California, United States

Study of Time-restricted Eating on Weight Loss.

Not Applicable

Completed

Conditions: Insulin Resistance
Obesity

Interventions: Behavioral: Consistent Meal timing plan
Behavioral: Time-restricted Eating plan

First Posted Date: 2018-01-08

Last Posted Date: 2020-03-03

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 137

Registration Number: NCT03393195

Locations: 🇺🇸
UCSF Medical Center, San Francisco, California, United States

Defibrotide TMA Prophylaxis Pilot Trial

Phase 2

Completed

Conditions: Thrombotic Microangiopathies

Interventions: Drug: Defibrotide

First Posted Date: 2017-12-27

Last Posted Date: 2021-09-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 25

Registration Number: NCT03384693

Locations: 🇺🇸
Benioff Children's Hospital at UCSF Medical Center, San Francisco, California, United States

Predictors of Outcomes in MBSR Participants From Teacher Factors

Completed

Conditions: Healthy

Interventions: Behavioral: MBSR

First Posted Date: 2017-12-27

Last Posted Date: 2024-07-03

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 219

Registration Number: NCT03384771

Locations: 🇺🇸
Center for Mindfulness at University of Massachussets, Boston, Massachusetts, United States
🇺🇸
Osher Center for Integrative Medicine, San Francisco, California, United States

Metformin, Vitamin D, and Depression in Polycystic Ovary Syndrome (PCOS) Trial

Phase 4

Terminated

Conditions: Vitamin D Deficiency
PCOS
Depression
Insulin Resistance

Interventions: Drug: Vitamin D
Drug: Metformin

First Posted Date: 2017-12-20

Last Posted Date: 2021-02-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 5

Registration Number: NCT03380091

Locations: 🇺🇸
UCSF Center for Reproductive Health, San Francisco, California, United States

Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction

Phase 2

Completed

Conditions: Restrictive Chronic Lung Allograft Dysfunction
Lung Transplant Rejection

Interventions: Drug: Pirfenidone

First Posted Date: 2017-12-02

Last Posted Date: 2023-06-29

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT03359863

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

An RCT of an Online Training for Vulnerable Patients to Use an Online Patient Portal Website

Not Applicable

Completed

Conditions: Electronic Health Records
Chronic Disease
Health Literacy

Interventions: Behavioral: Take-home online training
Behavioral: In-person online training

First Posted Date: 2017-11-27

Last Posted Date: 2019-04-19

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 93

Registration Number: NCT03354000

PERsonal ContExtual Precision healTh

Not Applicable

Completed

Conditions: Hypertension
Depression

Interventions: Behavioral: Mobile Health Monitoring

First Posted Date: 2017-11-22

Last Posted Date: 2019-03-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 164

Registration Number: NCT03349918

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Evaluating Multivariate MRI Maps of Body Awareness

Completed

Conditions: Attention

First Posted Date: 2017-11-17

Last Posted Date: 2021-09-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 16

Registration Number: NCT03344081

Locations: 🇺🇸
Osher Center for Integrative Medicine, San Francisco, California, United States

Mortality Reduction After Oral Azithromycin Contingency: Mortality Study

Phase 4

Completed

Conditions: Childhood Mortality

Interventions: Drug: Azithromycin
Drug: Placebo

First Posted Date: 2017-11-09

Last Posted Date: 2022-08-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 66228

Registration Number: NCT03338244

Locations: 🇳🇪
The Carter Center, Niamey, Niger
🇺🇸
UCSF Proctor Foundation, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy